Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Different scalp and hair disorders are more common in certain ethnic groups, with the most common being androgenetic alopecia, which is treated with medications like minoxidil and finasteride.

Female Pattern Hair Loss affects women's self-esteem and needs more research for better treatment.

SAHA syndrome is a condition in women involving skin and hair issues, often related to hormonal imbalances, and is treated based on the underlying cause.

Female pattern hair loss is common, linked to polycystic ovarian syndrome, and treated with topical Minoxidil.

Neuroactive steroids could become safe, effective treatments with more understanding of their complex brain actions and metabolism.

Puberty often causes skin issues like acne and excessive sweating, and treatments require patience as results may vary.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

New hair loss treatments may include topical medications, injections, and improved transplant methods.

Androgenetic alopecia is influenced by various factors and can be treated with medications, procedures, and non-drug methods.

Low level laser therapy works best for hair loss, followed by PRP, finasteride, and minoxidil.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Balding people may have higher heart disease risk.

Various treatments exist for hair loss, but more research is needed for better options.

Understanding normal hair growth and loss in children is key to diagnosing and treating hair disorders.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

Rare genetic variants in five specific genes are linked to male-pattern hair loss but only account for a small part of the risk.

Different ACE2 gene versions may affect COVID-19 impact based on age and suggest some hair loss drugs could be potential treatments.

Genetic factors could lead to personalized treatments for hair loss.

The document concludes that inflammation markers can be used in diabetes, vitamin D3 affects immune pathways, hyperthyroidism changes hormone levels, androgen levels help diagnose Adrenocortical Carcinoma, erectile dysfunction is linked to diabetes, hypogonadism is common in HIV-infected males, and hormones can be biomarkers for various conditions.

Men with higher androgen levels may have severe COVID-19 symptoms, but those on antiandrogen therapy are less likely to contract the virus and have milder symptoms. Anti-androgen drugs could potentially treat COVID-19, but more research is needed.

Understanding genes and hormones is crucial for managing male puberty and sex development disorders.

Skin lesions in Carney Complex are caused by a gene change in some skin cells that leads to increased pigmentation and may lead to tumors.

Genes linked to wool fineness in sheep have been identified.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

The conclusion is that more research is needed to understand if the drug finasteride causes Post-Finasteride Syndrome or if it's due to individual genetic makeup.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

Hormone therapy for prostate cancer can increase heart risks, especially in men with heart conditions.

Testosterone and its metabolites have varied effects on different body systems, especially during puberty.